Free Trial

Summit Therapeutics (SMMT) SEC Filings & 10K Form

Summit Therapeutics logo
$20.79 +1.60 (+8.34%)
Closing price 04:00 PM Eastern
Extended Trading
$20.62 -0.16 (-0.79%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Summit Therapeutics SEC Filings

DateFilerForm TypeView
02/24/2025
5:53 AM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
5:08 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:23 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:06 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:37 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:49 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:24 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:30 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:39 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:17 PM
Cesano Alessandra (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:57 PM
Booth Robert F. (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:11 PM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:33 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:06 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:08 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:54 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
4:28 PM
Summit Therapeutics (Filer)
Form S-3ASR
09/13/2024
6:29 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:25 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:54 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
09/13/2024
4:40 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:26 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:29 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:49 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:23 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:14 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:37 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2024
4:20 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:16 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
3:27 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:14 PM
Summit Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/17/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
1:03 PM
Summit Therapeutics (Filer)
Form DEFA14A
06/03/2024
5:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
5:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
3:48 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:35 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:48 AM
Summit Therapeutics (Filer)
Form 424B5
05/01/2024
7:45 AM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Crypto’s crashing…but we’re still profiting (Ad)

Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…

my friend Joel and his team at The Crypto Code are doing the opposite.
05/01/2024
7:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:11 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
8:21 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
8:19 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2024
3:35 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
4:52 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:43 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2024
4:47 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:42 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:27 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:28 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SMMT) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners